IBDEI1AL ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,22891,1,5,0)
 ;;=5^Otitis Media
 ;;^UTILITY(U,$J,358.3,22891,2)
 ;;=^123967
 ;;^UTILITY(U,$J,358.3,22892,0)
 ;;=614.9^^125^1398^50
 ;;^UTILITY(U,$J,358.3,22892,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22892,1,4,0)
 ;;=4^614.9
 ;;^UTILITY(U,$J,358.3,22892,1,5,0)
 ;;=5^Pelvic Inflammatory Disease
 ;;^UTILITY(U,$J,358.3,22892,2)
 ;;=^3537
 ;;^UTILITY(U,$J,358.3,22893,0)
 ;;=486.^^125^1398^52
 ;;^UTILITY(U,$J,358.3,22893,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22893,1,4,0)
 ;;=4^486.
 ;;^UTILITY(U,$J,358.3,22893,1,5,0)
 ;;=5^Pneumonia
 ;;^UTILITY(U,$J,358.3,22893,2)
 ;;=^95632
 ;;^UTILITY(U,$J,358.3,22894,0)
 ;;=136.3^^125^1398^51
 ;;^UTILITY(U,$J,358.3,22894,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22894,1,4,0)
 ;;=4^136.3
 ;;^UTILITY(U,$J,358.3,22894,1,5,0)
 ;;=5^Pneumocystosis
 ;;^UTILITY(U,$J,358.3,22894,2)
 ;;=^95635
 ;;^UTILITY(U,$J,358.3,22895,0)
 ;;=601.9^^125^1398^56
 ;;^UTILITY(U,$J,358.3,22895,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22895,1,4,0)
 ;;=4^601.9
 ;;^UTILITY(U,$J,358.3,22895,1,5,0)
 ;;=5^Prostatitis NOS
 ;;^UTILITY(U,$J,358.3,22895,2)
 ;;=^99489
 ;;^UTILITY(U,$J,358.3,22896,0)
 ;;=590.80^^125^1398^57
 ;;^UTILITY(U,$J,358.3,22896,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22896,1,4,0)
 ;;=4^590.80
 ;;^UTILITY(U,$J,358.3,22896,1,5,0)
 ;;=5^Pyelonephritis NOS
 ;;^UTILITY(U,$J,358.3,22896,2)
 ;;=^101463
 ;;^UTILITY(U,$J,358.3,22897,0)
 ;;=711.00^^125^1398^58
 ;;^UTILITY(U,$J,358.3,22897,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22897,1,4,0)
 ;;=4^711.00
 ;;^UTILITY(U,$J,358.3,22897,1,5,0)
 ;;=5^Septic Joint
 ;;^UTILITY(U,$J,358.3,22897,2)
 ;;=^263780
 ;;^UTILITY(U,$J,358.3,22898,0)
 ;;=461.9^^125^1398^60
 ;;^UTILITY(U,$J,358.3,22898,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22898,1,4,0)
 ;;=4^461.9
 ;;^UTILITY(U,$J,358.3,22898,1,5,0)
 ;;=5^Sinusitis, Acute
 ;;^UTILITY(U,$J,358.3,22898,2)
 ;;=^259080
 ;;^UTILITY(U,$J,358.3,22899,0)
 ;;=473.9^^125^1398^59
 ;;^UTILITY(U,$J,358.3,22899,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22899,1,4,0)
 ;;=4^473.9
 ;;^UTILITY(U,$J,358.3,22899,1,5,0)
 ;;=5^Sinusitis Chronic
 ;;^UTILITY(U,$J,358.3,22899,2)
 ;;=^123985
 ;;^UTILITY(U,$J,358.3,22900,0)
 ;;=091.0^^125^1398^65
 ;;^UTILITY(U,$J,358.3,22900,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22900,1,4,0)
 ;;=4^091.0
 ;;^UTILITY(U,$J,358.3,22900,1,5,0)
 ;;=5^Syphilis,Primary Genital
 ;;^UTILITY(U,$J,358.3,22900,2)
 ;;=^50581
 ;;^UTILITY(U,$J,358.3,22901,0)
 ;;=097.0^^125^1398^63
 ;;^UTILITY(U,$J,358.3,22901,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22901,1,4,0)
 ;;=4^097.0
 ;;^UTILITY(U,$J,358.3,22901,1,5,0)
 ;;=5^Syphilis,Latent
 ;;^UTILITY(U,$J,358.3,22901,2)
 ;;=^266781
 ;;^UTILITY(U,$J,358.3,22902,0)
 ;;=094.9^^125^1398^64
 ;;^UTILITY(U,$J,358.3,22902,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22902,1,4,0)
 ;;=4^094.9
 ;;^UTILITY(U,$J,358.3,22902,1,5,0)
 ;;=5^Syphilis,Neurosyphilis
 ;;^UTILITY(U,$J,358.3,22902,2)
 ;;=^83026
 ;;^UTILITY(U,$J,358.3,22903,0)
 ;;=097.9^^125^1398^62
 ;;^UTILITY(U,$J,358.3,22903,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22903,1,4,0)
 ;;=4^097.9
 ;;^UTILITY(U,$J,358.3,22903,1,5,0)
 ;;=5^Syphilis NOS
 ;;^UTILITY(U,$J,358.3,22903,2)
 ;;=^116808
 ;;^UTILITY(U,$J,358.3,22904,0)
 ;;=463.^^125^1398^66
 ;;^UTILITY(U,$J,358.3,22904,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22904,1,4,0)
 ;;=4^463.
 ;;^UTILITY(U,$J,358.3,22904,1,5,0)
 ;;=5^Tonsillitis
 ;;^UTILITY(U,$J,358.3,22904,2)
 ;;=^2695
 ;;^UTILITY(U,$J,358.3,22905,0)
 ;;=130.9^^125^1398^67
 ;;^UTILITY(U,$J,358.3,22905,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22905,1,4,0)
 ;;=4^130.9
 ;;
 ;;$END ROU IBDEI1AL
